T2期腋窝淋巴结1～3个转移乳腺癌改良根治术后放疗对局部区域控制的影响及生存预后因素分析(3)
 |
| 第1页 |
参见附件。
[6] Kim SI， Park S， Park HS， et al. Comparison of treatment outcome between breast-conservation surgery with radiation and total mastectomy without radiation in patients with one to three positive axillary lymph nodes[J]. Int J Radiat Oncol Biol Phys，2011，80(5)：1446-1452.
[7] 中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2013版)[J].中国癌症杂志，2013(8)：637-684.
[8] Jeong Y， Kim SS， Gong G， et al.Treatment results of breast cancer patients with locoregional recurrence after mastectomy[J]. Radiat Oncol J， 2013，31(3)：138-146.
[9] Li Y， Moran MS， Huo Q， et al.Post-mastectomy radiotherapy for breast cancer patients with t1-t2 and 1-3 positive lymph nodes： a meta-analysis[J].PLoS One，2013，8(12)：e81765.
[10] Su YL， Li SH， Chen YY，et al.Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis[J].Radiol Oncol，2014 ，48(3)：314-322.
[11] Oh JL， Bonnen M， Outlaw ED，et al. The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger： How young is "young"[J]. Int J Radiat Oncol Biol Phys，2006，65(5)：1345-1352.
(收稿日期：2014-07-25)
您现在查看是摘要介绍页，详见PDF附件。